AIDS – HealthQuill

The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability of a rectal microbicide douche containing the antiretroviral drug tenofovir to prevent HIV infection spread among men.

Mid-stage trial of a rectal microbicide for HIV prevention in the US begins

HQ Team November 3, 2024: The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability.

by HealthQuill
November 3, 2024
0 Comments

HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups than in the placebo or dummy group.

Drugs Health Pharma

PrEPVacc HIV trials’ results ‘surprising’ as dummy group clocks less infections

HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups.

by HealthQuill
July 24, 2024
0 Comments

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9 million HIV people not able to receive treatment owing to a shortage of funds and an anti-rights push, a report stated.

Drugs Health Pharma

Fund crunch, anti-rights push, slowing global target to end AIDS, UN says

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9.

by HealthQuill
July 23, 2024
0 Comments

US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering the feasibility of processing pharmaceuticals in microgravity.

Drugs Health Pharma

US-based Varda Space crystallises HIV drug in microgravity

HQ Team March 31, 2024: US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering.

by HealthQuill
March 31, 2024
0 Comments

British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and tablets, cabotegravir, to prevent HIV.

Drugs Health Pharma

Britain’s GSK gets EMA clearance for drug to prevent HIV

HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and.

by HealthQuill
July 24, 2023
0 Comments

The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new infections and deaths are falling, some nations are experiencing rising incidence, the WHO stated.

Drugs Health Pharma

Challenges to fight HIV remain, funding ‘precarious’: WHO

HQ Team July 24, 2023: The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new.

by HealthQuill
July 24, 2023
0 Comments

The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the US, according to a statement from the regulator.

Drugs Health Pharma

USFDA allows first oral contraceptive without a prescription

HQ Team July 14, 2023: The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the.

by HealthQuill
July 14, 2023
0 Comments

Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for developing and marketing a drug to prevent HIV.

Drugs Health Medical Pharma

Aurobindo Pharma signs licensing pact with UN body to fight HIV

Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for.